Takahashi, Nana
Kiyota, Naoki
Kunikata, Hiroshi
Yamazaki, Mai
Nishimura, Takayuki
Shiga, Yukihiro
Aoyagi, Hisae
Shidomi, Miwako
Tsuda, Tomohiro
Ohtsuka, Toshihiko
Tomida, Takahiro
Nakazawa, Toru
Funding for this research was provided by:
JST COI (JPMJCE1303)
JSPS KAKENHI Grants-in-Aid for Scientific Research (26293372)
JSPS KAKENHI Grants-in-Aid for Exploratory Research (26670751)
Article History
Received: 16 March 2023
Accepted: 23 June 2023
First Online: 12 July 2023
Declarations
:
: This study adhered to the tenets of the Declaration of Helsinki, and the protocols were approved by the Clinical Research Ethics Committee of the Tohoku University Graduate School of Medicine (study 2021–1-434). Written informed consent was obtained from the subjects before the CPT was performed. No patient was individually identified in this study.
: All study participants provided written informed consent for the publication of any potentially identifying information or images.
: Co-authors HA, MS, and TT are employed by Rohto Pharmaceutical Co., Ltd., a commercial company. Co-authors TO and TT are employed by Casio Computer Co., Ltd., a commercial company. TN receives financial support from Rohto Pharmaceutical Co., Ltd., and provision of study material equipment from Casio Computer Co., Ltd. There are no patents, products in development, or marketed products to declare. The other authors have no potential conflicts of interest associated with this manuscript.